An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adult Males With Fabry Disease
收藏DataMed2026-07-14 收录
官方服务：
资源简介：
This is a prospective multicenter, open-label, dose-escalation trial to assess the safety, tolerability, and pharmacodynamics of 4D-310 following a single IV administration. The study population is comprised of adult males with Fabry Disease.
提供机构：
ClinicalTrials.gov
